Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics NICE consultation on enhancing the BNF with other prescribing resources: an opportunity to lobby for the Palliative Care Formulary NICE has opened a consultation on the future format of the British National Formulary (BNF) and […]
Category: Updates from www.palliativedrugs.com
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics New drug driving offence – changes to SPCs and product labelling The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued information about changes that will be made to UK SPCs, PILs and product […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions Palliativedrugs.com on twitter Follow us @palliativedrugs for information on updates to the on-line PCF, latest additions to the website and news related to drug use in palliative care. PCF updated monographs The online Palliative Care […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates Class 4 drug alert: Matrifen 100microgram/h TD patches The UK Medicines and Healthcare products Regulatory Agency (MHRA) have issued a Class 4 drug alert (caution in use) for the Matrifen brand of fentanyl 100microgram/h transdermal […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions Strong Opioid Identification Booklet now available! Palliativedrugs.com Ltd. has produced a Strong Opioid Identification Booklet. This new resource is designed to be used in two ways: • as a quick reference guide for the range of […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Diamorphine nasal spray launched in UK A diamorphine nasal spray (Ayendi; Wockhardt) indicated for the treatment of acute severe nociceptive pain in children and adolescents 2–15years old in a hospital setting, is now available as an […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Consultation on end of life care guidance The Leadership Alliance for the Care of Dying People (LACDP), set up in response to the recommendations from the independent report into the Liverpool Care Pathway (see news […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates EMA confirms metoclopramide restrictions The European Medicines Agency (EMA) has re-examined the recommended changes for metoclopramide in adults and children that it made in July 2013, following a request from one of the marketing authorization […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates EMA restricts metoclopramide dose and duration of use The European Medicines Agency (EMA) recommended changes to the dose and duration of use of metoclopramide in adults and children in July 2013, following a review. They […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates Updated IV Ondansetron dosing for CINV The UK MHRA has given new guidance for the administration of IV ondansetron based on further information on the risk of dose-dependent QT interval prolongation, (first reported in August […]